Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease

The past decade has resulted in multiple new findings of potential proteomic biomarkers of diabetic kidney disease (DKD). Many of these biomarkers reflect an important role in the (patho)physiology and biological processes of DKD. Situations in which proteomics could be applied in clinical practice...

Descripción completa

Detalles Bibliográficos
Autores principales: Pena, Michelle J., Mischak, Harald, Heerspink, Hiddo J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969331/
https://www.ncbi.nlm.nih.gov/pubmed/27344310
http://dx.doi.org/10.1007/s00125-016-4001-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969331/
https://www.ncbi.nlm.nih.gov/pubmed/27344310
http://dx.doi.org/10.1007/s00125-016-4001-9

Ejemplares similares